Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Vimu3g03145 ATGGAAGATAATGGTCTGGCGCCGTTGTTCTATGTTGGCCACCACAAGTTGAAGCTTCTCATGTCTCCTCTTCTGCTCATGCTCTTCCTTCTCTTTCCATTTGCTTTGCCCCTCAGCGAAGAAGACATTCGACTCTGCGGTGTTTTTGTCGGGGTTTTAGATATTTACGATGCTGAATTTAGTGAAACAACCGTGGGACAAGCATTAATGGCGATGAAGGCCACTTTCAGCAATATGGCAGACGTGCTTCTTGACTGGGATGACGTCCACAATGACGACTTTTGCTCTTGGCGTGGAGTTTTCTGCGATAATGGCAGCCTTACTGTGATTTCTCTGAACTTGTCCAGCTTGAACCTCGGCGGGGAGATATCCCCAGCCATTGGTGACTTGAGAAACTTGCAGTCCATAGACTTGCAAGGGAATAAATTAACGGGGCAAATCCCAGATGAAATTGGAAACTGTGCAGCACTTTTTCTTTTGGATTTGTCTGATAATCACCTTTATGGTGATATACCTTTCTCCCTGTCAAAGCTAAAGCAACTTGAGTTTTTGAATTTAAAGAGTAATCAGTTAACTGGCCCTATCCCTTCAACTCTAACCCAAATTCCAAATCTTAAGACTCTTGATCTTGCTCGAAATAGGCTCACAGGAGAGATCCCCAGATTACTCTATTGGAATGAAGTCTTGCAGTACCTTGGGTTACGAGGAAACATGTTGAGTGGTACTCTGTCTCCTGATATATGTCAATTAACTGGATTGTGGTATTTTGATGTGAGAGGCAACAATTTGACTGGTACTATACCTGACAGCATAGGGAACTGTACAAGTTTTGAAATCTTAGACATATCATATAATCAGATTACTGGAGAGATTCCATATAATATTGGGTTTCTGCAAGTTGCCACTTTGTCACTTCAAGGGAATAGATTAACTGGGAAGATTCCAGAAGTTATTGGTTTGATGCAAGCCCTTGCAATATTGGATTTGAGTGAGAATGAGTTAGTGGGATCAATTCCCCCAATACTTGGGAATCTGACCTTCACCGGAAAGCTGTACCTTCATGGAAACATGCTTACTGGCCCGATACCTCCTGAACTAGGCAATATGTCCAAACTGAGCTACTTGCAATTGAATGACAACCACCTAATTGGAAAAATTCCAAATGAGTTTGGGAAGCTTGAACATCTTTTTGAATTGAATCTTGCCAATAATCATTTTGATGGAACTATTCCACGTAACATAAGCTCCTGCACAGCCTTAAATCAGTTTAATGTGCATGGTAATCAGTTGAGTGGTTCCATTCCATTGAGCTTCCGCAACCTTGGTAGTTTGACATACTTAAACCTCTCTGCGAACAACTTCAAGGGGACCATACCTGTTGAGTTGGGGCATATTATTAATCTAGATACATTGGATCTATCTTGCAATAATTTTTCAGGACTTGTTCCCGCATCTGTTGGTTATCTGGAACATCTCTTGACCCTCAACTTAAGTCACAACCACCTTGGAGGTTCCTTGCCAGCTGAATTTGGGAATCTCAGAAGCATTCAAATTCTTGATATGTCATTCAACAATCTCTCTGGTAGCATTCCTCCGGAAATTGGACAGCTGCAGAACCTTATGTCTTTGATTATGAACAACAATGATCTGCGAGGGAAGATTCCTGATCAGATGACTAATTGTTTTAGTCTTACACTATTAAATTTGTCCTATAACAACCTTTCCGGAGTAATTCCTTCAATGAAGAACTTTTCAAGGTTTTCAGCTGACAGCTTCTTCGGAAATTCATTATTATGTGGAGATTGGGTGGGATCAATATGTCGTCCTTACATTCCAAAATCAAGAGTGATTTTCTCCAGAGTTGCTGTAGTATGTCTCACGCTTGGAATTATGATATTGTTAGCCATGGTCATTGTAGCCTTCTATAGATCCAGCCAATCTAAACAATTGATGAAGGGATCTAGCAGAACTGGGCAAGGTCCACCAAGACTAGTTATTCTGCACATGGATATGGCTATCCACACCTTGGACGATATAATGAGAAGCACTGAGAATCTCAATGAGAAATATATCATAGGTTATGGTGCCTCTAGTACTGTATACAAATGTGTTTTGAAGAATTCCCGACCAATTGCAGTTAAGCGACTGTATAACCAACACCCACACAATTTAAGGGAGTTTGAGACCGAACTTGAGACAGTTGGTAGCATCAGACATAGAAACCTTGTCACCTTGCATGGATATGCACTCACTCCCGATGGAAATCTTCTTTTCTATGACTATATGGCCAATGGGTCATTGTGGGATCTTCTACACGATGTTTCACCTGATGCAGGTCCCTCGAAGGTAAAACTTGATTGGGAAACACGCCTGAGGATTGCTGTTGGAGCAGCCGAAGGACTGGCTTATCTCCATCATGACTGTAACCCTCGAATAGTTCACAGGGACATTAAATCTTCGAATATTTTGCTGGATGAGAACTTCGAGGCTCATCTCTCTGATTTTGGTACTGCAAAGTGCATCTCGACCTCGAGAACTCATGCATCGACCTATGTCCTTGGAACTATTGGCTATATTGACCCTGAGTATGCCCGAACATCTAGGCTGAATGAAAAATCAGATGTGTATAGCTTTGGCATAGTTCTTTTGGAACTACTGACTGGAAAGAAGGCAGTGGACAATGAGTCTAATTTGCATCAATTGATATTGGCCAAGACAGACAACAACACTGTAATGGAGGCTGTTGATGCAGAGGTGTCTATAACCTGCATTGATCTAGCTCATGTTAAGAAGACCTTTCAGCTTGCTCTTCTTTGCACGAAAAAGAACCCTTCTGATAGGCCTACCATGCATGAAGTAGCCAGGGTTCTGGTATCACTGCTTCCTTCACCTCCAAGTAAGATCCTTGCTCCACCTGCAAAGAAATTTGACTATGCCCATTTTGTGATCGAGAAGGGACAACCTCGAAAAGTTGAAGGACAACCTCACCAAGAAGATAACAACTCAACCAATGCTCAATGGTTCGTTCGCTTTGGGGATGTTATATCCAAGAGCACTTGA 3060 0.419 MEDNGLAPLFYVGHHKLKLLMSPLLLMLFLLFPFALPLSEEDIRLCGVFVGVLDIYDAEFSETTVGQALMAMKATFSNMADVLLDWDDVHNDDFCSWRGVFCDNGSLTVISLNLSSLNLGGEISPAIGDLRNLQSIDLQGNKLTGQIPDEIGNCAALFLLDLSDNHLYGDIPFSLSKLKQLEFLNLKSNQLTGPIPSTLTQIPNLKTLDLARNRLTGEIPRLLYWNEVLQYLGLRGNMLSGTLSPDICQLTGLWYFDVRGNNLTGTIPDSIGNCTSFEILDISYNQITGEIPYNIGFLQVATLSLQGNRLTGKIPEVIGLMQALAILDLSENELVGSIPPILGNLTFTGKLYLHGNMLTGPIPPELGNMSKLSYLQLNDNHLIGKIPNEFGKLEHLFELNLANNHFDGTIPRNISSCTALNQFNVHGNQLSGSIPLSFRNLGSLTYLNLSANNFKGTIPVELGHIINLDTLDLSCNNFSGLVPASVGYLEHLLTLNLSHNHLGGSLPAEFGNLRSIQILDMSFNNLSGSIPPEIGQLQNLMSLIMNNNDLRGKIPDQMTNCFSLTLLNLSYNNLSGVIPSMKNFSRFSADSFFGNSLLCGDWVGSICRPYIPKSRVIFSRVAVVCLTLGIMILLAMVIVAFYRSSQSKQLMKGSSRTGQGPPRLVILHMDMAIHTLDDIMRSTENLNEKYIIGYGASSTVYKCVLKNSRPIAVKRLYNQHPHNLREFETELETVGSIRHRNLVTLHGYALTPDGNLLFYDYMANGSLWDLLHDVSPDAGPSKVKLDWETRLRIAVGAAEGLAYLHHDCNPRIVHRDIKSSNILLDENFEAHLSDFGTAKCISTSRTHASTYVLGTIGYIDPEYARTSRLNEKSDVYSFGIVLLELLTGKKAVDNESNLHQLILAKTDNNTVMEAVDAEVSITCIDLAHVKKTFQLALLCTKKNPSDRPTMHEVARVLVSLLPSPPSKILAPPAKKFDYAHFVIEKGQPRKVEGQPHQEDNNSTNAQWFVRFGDVISKST 1019
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Vimu3g03145 1019 FunFam LRR receptor-like serine/threonine-protein kinase ERL1 337 610 - -
Vimu3g03145 1019 Pfam Leucine rich repeat 467 526 IPR001611 GO:0005515
Vimu3g03145 1019 ProSiteProfiles Protein kinase domain profile. 686 961 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vimu3g03145 1019 Gene3D Ribonuclease Inhibitor 226 338 IPR032675 -
Vimu3g03145 1019 Pfam Protein kinase domain 688 954 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vimu3g03145 1019 Gene3D Transferase(Phosphotransferase) domain 1 762 965 - -
Vimu3g03145 1019 PANTHER RECEPTOR KINASE-LIKE PROTEIN XA21 500 585 - -
Vimu3g03145 1019 ProSiteProfiles Leucine-rich repeat profile. 204 226 IPR001611 GO:0005515
Vimu3g03145 1019 FunFam LRR receptor-like serine/threonine-protein kinase ERECTA 657 761 - -
Vimu3g03145 1019 ProSitePatterns Protein kinases ATP-binding region signature. 692 714 IPR017441 GO:0005524
Vimu3g03145 1019 FunFam LRR receptor-like serine/threonine-protein kinase ERL1 63 226 - -
Vimu3g03145 1019 SUPERFAMILY Protein kinase-like (PK-like) 664 957 IPR011009 -
Vimu3g03145 1019 SMART LRR_typ_2 441 465 IPR003591 -
Vimu3g03145 1019 SMART LRR_typ_2 489 512 IPR003591 -
Vimu3g03145 1019 SMART LRR_typ_2 369 392 IPR003591 -
Vimu3g03145 1019 SMART LRR_typ_2 178 201 IPR003591 -
Vimu3g03145 1019 SMART LRR_typ_2 250 274 IPR003591 -
Vimu3g03145 1019 SMART LRR_typ_2 393 417 IPR003591 -
Vimu3g03145 1019 SMART LRR_typ_2 513 537 IPR003591 -
Vimu3g03145 1019 SMART LRR_typ_2 130 154 IPR003591 -
Vimu3g03145 1019 SMART LRR_typ_2 202 226 IPR003591 -
Vimu3g03145 1019 SMART LRR_typ_2 321 345 IPR003591 -
Vimu3g03145 1019 SUPERFAMILY L domain-like 67 359 - -
Vimu3g03145 1019 Gene3D Phosphorylase Kinase; domain 1 652 761 - -
Vimu3g03145 1019 Gene3D Ribonuclease Inhibitor 339 609 IPR032675 -
Vimu3g03145 1019 FunFam LRR receptor-like serine/threonine-protein kinase ERECTA 762 967 - -
Vimu3g03145 1019 Gene3D Ribonuclease Inhibitor 64 225 IPR032675 -
Vimu3g03145 1019 Pfam Leucine rich repeat N-terminal domain 66 103 IPR013210 -
Vimu3g03145 1019 FunFam LRR receptor-like serine/threonine-protein kinase ERL1 227 336 - -
Vimu3g03145 1019 SUPERFAMILY RNI-like 267 582 - -
Vimu3g03145 1019 SMART serkin_6 686 958 IPR000719 GO:0004672|GO:0005524|GO:0006468
Vimu3g03145 1019 Pfam Leucine Rich repeat 273 290 IPR001611 GO:0005515
Vimu3g03145 1019 Pfam Leucine Rich repeat 203 218 IPR001611 GO:0005515
Vimu3g03145 1019 ProSitePatterns Serine/Threonine protein kinases active-site signature. 812 824 IPR008271 GO:0004672|GO:0006468
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Vimu3g03145 Vimu-Chr3 45234662 45242813 Dispersed/Wgd
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Vimu3g03145 298 580 Receptor kinase-like Gene Family AT5G07180 39.576 3.99e-45 174
       

Transcription factors information

Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
PK RLK-Pelle_LRR-XIIIb Vimu3g03145 Pkinase 3.9e-43 CL0016
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Vimu3g03145 K20718 - gmx:100811653 1737.62